메뉴 건너뛰기




Volumn 98, Issue 5, 2013, Pages 525-532

Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B

Author keywords

Efficacy; Hemophilia B; Pharmacokinetics; Rfix; Safety

Indexed keywords

BAX 326; BLOOD CLOTTING FACTOR 9 CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 9; UNCLASSIFIED DRUG;

EID: 84892946426     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1448-z     Document Type: Article
Times cited : (16)

References (21)
  • 1
    • 51249118258 scopus 로고    scopus 로고
    • Structural analysis of factor IX protein variants to predict functional aberration causing haemophilia B
    • Mukherjee S, Saha A, Biswas P, Mandal C, Ray K. Structural analysis of factor IX protein variants to predict functional aberration causing haemophilia B. Haemophilia. 2008;14:1076-81.
    • (2008) Haemophilia , vol.14 , pp. 1076-1081
    • Mukherjee, S.1    Saha, A.2    Biswas, P.3    Mandal, C.4    Ray, K.5
  • 2
    • 33645961280 scopus 로고    scopus 로고
    • Insight into molecular changes of the FIX protein in a series of Italian patients with haemophilia B
    • Bicocchi MP, Pasino M, Rosano C, Molinari AC, Della VE, Lanza T, et al. Insight into molecular changes of the FIX protein in a series of Italian patients with haemophilia B. Haemophilia. 2006;12:263-70.
    • (2006) Haemophilia , vol.12 , pp. 263-270
    • Bicocchi, M.P.1    Pasino, M.2    Rosano, C.3    Molinari, A.C.4    Della, V.E.5    Lanza, T.6
  • 3
    • 0031841277 scopus 로고    scopus 로고
    • Haemophilia B: Database of point mutations and short additions and deletions-eighth edition
    • Giannelli F, Green PM, Sommer SS, Poon M, Ludwig M, Schwaab R, et al. Haemophilia B: database of point mutations and short additions and deletions-eighth edition. Nucleic Acids Res. 1998;26:265-8.
    • (1998) Nucleic Acids Res , vol.26 , pp. 265-268
    • Giannelli, F.1    Green, P.M.2    Sommer, S.S.3    Poon, M.4    Ludwig, M.5    Schwaab, R.6
  • 4
    • 0027434188 scopus 로고
    • Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: Parallel evaluation of other markers for lipidenveloped and non-lipid-enveloped viruses
    • The Ad Hoc Study Group of the Fondazione dell'Emofilia
    • Mariani G, Di Paolantonio T, Baklaya R, Morfini M, Mannucci PM. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipidenveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia. Transfusion. 1993;33:814-8.
    • (1993) Transfusion , vol.33 , pp. 814-818
    • Mariani, G.1    Di Paolantonio, T.2    Baklaya, R.3    Morfini, M.4    Mannucci, P.M.5
  • 5
    • 0028136537 scopus 로고
    • Review of the hepatitis A epidemics in hemophiliacs in Europe
    • Vermylen J, Peerlinck K. Review of the hepatitis A epidemics in hemophiliacs in Europe. Vox Sang. 1994;67(Suppl 4):8-11.
    • (1994) Vox Sang , vol.67 , Issue.SUPPL. 4 , pp. 8-11
    • Vermylen, J.1    Peerlinck, K.2
  • 6
    • 0023898771 scopus 로고
    • Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates
    • Bartolomei Corsi O, Azzi A, Morfini M, Fanci R, Rossi Ferrini P. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol. 1988;25:165-70.
    • (1988) J Med Virol , vol.25 , pp. 165-170
    • Bartolomei, C.O.1    Azzi, A.2    Morfini, M.3    Fanci, R.4    Rossi, F.P.5
  • 7
    • 0029983755 scopus 로고    scopus 로고
    • Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate
    • Yee TT, Cohen BJ, Pasi KJ, Lee CA. Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate. Br J Haematol. 1996;93:457-9.
    • (1996) Br J Haematol , vol.93 , pp. 457-459
    • Yee, T.T.1    Cohen, B.J.2    Pasi, K.J.3    Lee, C.A.4
  • 8
    • 34248532042 scopus 로고    scopus 로고
    • Reformulated Bene FIX: Efficacy and safety in previously treated patients with moderately severe to severe haemophilia B
    • Lambert T, Recht M, Valentino LA, Powell JS, Udata C, Sullivan ST, et al. Reformulated BeneFix: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B. Haemophilia. 2007;13:233-43.
    • (2007) Haemophilia , vol.13 , pp. 233-243
    • Lambert, T.1    Recht, M.2    Valentino, L.A.3    Powell, J.S.4    Udata, C.5    Sullivan, S.T.6
  • 9
    • 13244277651 scopus 로고    scopus 로고
    • Enhanced factor VIII activity measurements using ROTEG and factor VIII- mice whole blood
    • Landskroner KA, Olson NC, Jesmok GJ. Enhanced factor VIII activity measurements using ROTEG and factor VIII- mice whole blood. J Thromb Haemost. 2004;2:2274-5.
    • (2004) J Thromb Haemost , vol.2 , pp. 2274-2275
    • Landskroner, K.A.1    Olson, N.C.2    Jesmok, G.J.3
  • 10
    • 22744458031 scopus 로고    scopus 로고
    • Thromboelastography measurements of whole blood from factor VIII-deficient mice supplemented with rFVIII
    • Landskroner KA, Olson NC, Jesmok GJ. Thromboelastography measurements of whole blood from factor VIII-deficient mice supplemented with rFVIII. Haemophilia. 2005;11:346-52.
    • (2005) Haemophilia , vol.11 , pp. 346-352
    • Landskroner, K.A.1    Olson, N.C.2    Jesmok, G.J.3
  • 12
    • 84940137996 scopus 로고
    • Biologic assay of a thrombosis- inducing activity in human serum
    • Wessler S, Reimer SM, Sheps MC. Biologic assay of a thrombosis- inducing activity in human serum. J Appl Physiol. 1959;14:943-6.
    • (1959) J Appl Physiol , vol.14 , pp. 943-946
    • Wessler, S.1    Reimer, S.M.2    Sheps, M.C.3
  • 13
    • 84892923759 scopus 로고    scopus 로고
    • A pharmacologic evaluation of BAY 79-4980 (liposomeformulated kogenate FS) in the hemophilia A mouse
    • Jesmok G, Cui ZH, Canivel D, Frounel M, Pierce G, Landskroner KA. A pharmacologic evaluation of BAY 79-4980 (liposomeformulated kogenate FS) in the hemophilia A mouse. Blood. 2006;11:108.
    • (2006) Blood , vol.11 , pp. 108
    • Jesmok, G.1    Cui, Z.H.2    Canivel, D.3    Frounel, M.4    Pierce, G.5    Landskroner, K.A.6
  • 14
    • 84892942889 scopus 로고    scopus 로고
    • Comparison of human rFVIII and murine rFVIII in a standardized FVIII dependent bleed model in FVIII - mice
    • Jesmok G, Cui ZH, Canivel D, Lollar P, Parker ET, Landskroner KA. Comparison of human rFVIII and murine rFVIII in a standardized FVIII dependent bleed model in FVIII - mice. J Thromb Haemost 2007;5 Suppl 2: 030.
    • (2007) J Thromb Haemost , vol.5 , Issue.SUPPL. 2 , pp. 030
    • Jesmok, G.1    Cui, Z.H.2    Canivel, D.3    Lollar, P.4    Parker, E.T.5    Landskroner, K.A.6
  • 15
    • 78650034120 scopus 로고    scopus 로고
    • Evaluation of PEG-FVIII molecules with prolonged half-lives in a murine FVIII-dependent bleeding model
    • Landskroner KA, Cui ZH, Newgren J, Fournel M, Pierce G, Jesmok G. Evaluation of PEG-FVIII molecules with prolonged half-lives in a murine FVIII-dependent bleeding model. Blood. 2006;11:108.
    • (2006) Blood , vol.11 , pp. 108
    • Landskroner, K.A.1    Cui, Z.H.2    Newgren, J.3    Fournel, M.4    Pierce, G.5    Jesmok, G.6
  • 16
    • 10144234803 scopus 로고    scopus 로고
    • Recombinant human factor IX: Replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B
    • Brinkhous KM, Sigman JL, Read MS, Stewart PF, McCarthy KP, Timony GA, et al. Recombinant human factor IX: replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B. Blood. 1996;88:2603-10.
    • (1996) Blood , vol.88 , pp. 2603-2610
    • Brinkhous, K.M.1    Sigman, J.L.2    Read, M.S.3    Stewart, P.F.4    McCarthy, K.P.5    Timony, G.A.6
  • 17
    • 84890859035 scopus 로고    scopus 로고
    • Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: A prospective, controlled, multicenter phase I/III study in previously treated patients with severe (FIX level\1 %) or moderately severe (FIX Level B 2%) haemophilia B
    • Epub ahead of print
    • Windyga J, Lissitchkov T, Stasyshyn O, Mamonov V. Rusen L, Lamas JL et al. Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: A prospective, controlled, multicenter phase I/III study in previously treated patients with severe (FIX level\1 %) or moderately severe (FIX Level B 2%) haemophilia B. Haemophilia. 2013 [Epub ahead of print].
    • (2013) Haemophilia
    • Windyga, J.1    Lissitchkov, T.2    Stasyshyn, O.3    Mamonov, V.R.L.4    Lamas, J.L.5
  • 18
    • 0028958843 scopus 로고
    • Measurement of activated factor IX in factor IX concentrates: Correlation with in vivo thrombogenicity
    • Gray E, Tubbs J, Thomas S, Oates A, Boisclair M, Kemball-Cook G, et al. Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicity. Thromb Haemost. 1995;73:675-9.
    • (1995) Thromb Haemost , vol.73 , pp. 675-679
    • Gray, E.1    Tubbs, J.2    Thomas, S.3    Oates, A.4    Boisclair, M.5    Kemball-Cook, G.6
  • 19
    • 33646262886 scopus 로고    scopus 로고
    • Overview of inhibitors
    • Astermark J. Overview of inhibitors. Semin Hematol. 2006;43:3-7.
    • (2006) Semin Hematol , vol.43 , pp. 3-7
    • Astermark, J.1
  • 20
    • 0038779279 scopus 로고    scopus 로고
    • Prophylaxis in factor IX deficiency product and patient variation
    • Kisker CT, Eisberg A, Schwartz B. Prophylaxis in factor IX deficiency product and patient variation. Haemophilia. 2003;9:279-84.
    • (2003) Haemophilia , vol.9 , pp. 279-284
    • Kisker, C.T.1    Eisberg, A.2    Schwartz, B.3
  • 21
    • 19944429262 scopus 로고    scopus 로고
    • The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B
    • Shapiro AD, Di Paola J, Cohen A, Pasi KJ, Heisel MA, Blanchette VS, et al. The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. Blood. 2005;105:518-25.
    • (2005) Blood , vol.105 , pp. 518-525
    • Shapiro, A.D.1    Di Paola, J.2    Cohen, A.3    Pasi, K.J.4    Heisel, M.A.5    Blanchette, V.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.